The most important risk factor for esophageal adenocarcinoma is Barret’s esophagus (BE), a pre-malignant condition in which the normal squamous lining in the esophagus has been replaced by a columnar epithelium containing intestinal metaplasia (IM) as a result of chronic gastroesophageal reflux disease. Nadine Phoa seeks to optimise endoscopic management strategies for patients with Barret’s esophagus containing dysplasia. To that end, she focuses on patients with dysplasia throughout the entire spectrum: from early cancers high-grade dysplasia to low-grade dysplasia patients.
K.Y.N. Phoa, Endoscopic Management of Barrett’s Esophagus with Dysplasia.
Prof. J.J.G.H.M. Bergman
Prof. J.G.P. Tijssen
Dr R.E. Pouw
Dr R.C. Mallant-Hent (Flevoziekenhuis)
This event is open to the public.